Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency

Medicine & Life Sciences

• Laron Syndrome 100%
• Insulin-Like Growth Factor Binding Proteins 80%
• Insulin-Like Growth Factor I 61%
• Insulin-Like Growth Factor Binding Protein 3 30%
• Serum 27%
• Insulin-Like Growth Factor II 22%
• insulin-like growth factor binding protein-3 protease 11%
• Therapeutics 10%
• Pharmacokinetics 9%
• Ecuador 8%
• Somatomedins 6%
• Gonadotropin-Releasing Hormone 6%
• Growth Hormone 5%
• Radioimmunoassay 5%
• Half-Life 5%
• Peptide Hydrolases 5%
• Ligands 4%
• Western Blotting 4%